References
Piscitelli SC, Burstein AH, Chait D, Alfaro RM, Fallon J (2000) Indinavir concentrations and St John’s worth. Lancet 355:547–548
De Smet PAGM (2006) Clinical risk management of herb–drug interactions. Br J Clin Pharmacol 63:258–267
Skalli S, Zaid A, Soulaymani R (2007) Drug interactions with herbal medicines. Ther Drug Monit 29:679–686
Budzinski JW, Foster BC, Vandenhoek S, Arnason JT (2000) An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 7(4):273–282
Ribera E, Lopez RM, Diaz M, Pou L, Ruiz L, Falco V, Crespo M, Azuaje C, Ruiz I, Ocaña I, Clotet B, Pahissa A (2004) Steady-state pharmacokinetics of a double-boosting regimen of saquinavir soft gel plus lopinavir plus minidose ritonavir in human immunodeficiency virus-infected adults. Antim Agents Chem 48:4256–4262
La Porte CJL, Back DJ, Blaschke T, Boucher CAB, Fletcher CV, Flexner C, Gerber JG, Kashuba ADM, Shapiro J, Burger DM (2006) Updated guideline to perform therapeutic drug monitoring for antiretrovirals agents. Rev Antiretroviral Ther 3:4–14
Horn JR, Hansten PD, Chan LN (2007) Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother 41:674–680
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
López Galera, R.M., Ribera Pascuet, E., Esteban Mur, J.I. et al. Interaction between cat’s claw and protease inhibitors atazanavir, ritonavir and saquinavir. Eur J Clin Pharmacol 64, 1235–1236 (2008). https://doi.org/10.1007/s00228-008-0551-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-008-0551-1